Eptifibatide is a cyclic heptapeptide pharmaceutical raw material that functions as a platelet aggregation inhibitor. It is a synthetic compound with multiple amide and amine functional groups, characterized by a complex macrocyclic structure containing a disulfide bridge and aromatic rings.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 188627-80-7
Triflusal
platelet aggregation inhibitor
Prasugrel
platelet aggregation inhibitor
(R)-N-Benzyl-1-(4-methoxyphenyl)propan-2-amine (S)-2-hydroxy-2-phenylacetate
active pharmaceutical ingredient
Streptozocin
antineoplastic agent and diabetogenic agent
4-(2-(tert-Butylamino)-1-hydroxyethyl)-2-methylphenol
active pharmaceutical ingredient
4-(2-(tert-Butylamino)-1-hydroxyethyl)-2-(methoxymethyl)phenol
Beta-2 adrenergic receptor agonist
(11-(4-Carbamimidamidobutyl)-3-carbamoyl-20-((1H-indol-3-yl)methyl)-1,9,12,15,18,21-hexaoxodocosahydro-7H-pyrrolo(2,1-g)(1,2,5,8,11,14,17,20)dithiahexaazacyclotricosin-17-yl)acetic acid
active pharmaceutical ingredient
2-[(3S,6S,12S,20R,23S)-20-carbamoyl-12-[4-(diaminomethylideneamino)butyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,22-hexaoxo-17,18-dithia-1,4,7,10,13,21-hexazabicyclo[21.3.0]hexacosan-6-yl]acetic acid
CZKPOZZJODAYPZ-LROMGURASA-N
C1C[C@H]2C(=O)N[C@@H](CSSCCC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N2C1)CC3=CNC4=CC=CC=C43)CC(=O)O)CCCCN=C(N)N)C(=O)N